产品中心
中间体
INTERMEDIATES
| Structure | Product Name | 品名 | Cas No. |
| Posaconazole 泊沙康唑 | |||
 |
1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine |
1-(4-氨基苯基)-4-(4-羟基苯基)哌嗪 | 74853-08-0 |
 |
phenyl N-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]carbamate | [4-[4-(4-羟基苯基)-1-哌嗪基]苯基]氨基甲酸苯酯 | 184177-81-9 |
 |
N-[[(2S,3S)-2-phenylmethoxypentan-3-yl]amino]formamide | 2-[(1S,2S)-1-乙基-2-苄氧基丙基]肼甲醛 | 170985-85-0 |
 |
[(2S,3S)-2-(benzyloxy)pentan-3-yl]hydrazine.L-DBTA Salt | [(1S,2S)-2-苄氧基-1-乙基丙基]肼D-二苯甲酰基酒石酸盐 | 183871-36-5 |
 |
2-[2-(2,4-Difluorophenyl)-2-propen-1-yl]-1,3-propanediol | 2-[2-(2,4-二氟苯基)-2-丙烯-1-基]-1,3-丙二醇 | 165115-73-1 |
 |
((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate | (5R-cis)-甲苯-4-磺酸5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯 | 149809-43-8 |
 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methyl 4-chlorobenzenesulfonate | 175712-02-4 | |
 |
2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one | 2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1-哌嗪基]苯基]-3H-1,2,4-三氮唑-3-酮 | 184177-83-1 |
 |
Posaconazole 泊沙康唑 | 171228-49-2 | |
| Voriconazole 伏立康唑 | |||
 |
4-Chloro-6-ethyl-5-fluoropyrimidine | 4-氯-6-乙基-5-氟嘧啶 | 137234-74-3 |
 |
2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone | 2',4'-二氟-2-(1H-1,2,4-三氮唑-1-基)苯乙酮 | 86404-63-9 |
 |
(2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2- (2,4-difluorophenyl)butan-2-ol hydrochloride |
(2R,3S/2S,3R)-3-(6-氯-5-氟嘧啶-4-基)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇盐酸盐 | 188416-35-5 |
 |
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4- pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (RaceMic Voriconazole) |
(R*,S*)3-(5-氟嘧啶-4-基)-2-（2,4-二氟苯基）-1-（1H-1,2,4-三唑-1-基）-2-丁醇 | 188416-29-7 |
 |
Voriconazole camphor sulfonate | (R*,S*)3-(5-氟嘧啶-4-基)-2-（2,4-二氟苯基）-1-（1H-1,2,4-三唑-1-基）-2-丁醇 R-(-)-10-樟脑磺酸盐 | 137234-71-0 |
| Isavuconazole 艾莎康唑 | |||
 |
1-[(2,6-difluorophenyl)methyl]triazole-4-carbonitrile | 4-氰基-1-(2,6-二氟苄基)-1H-1,2,3-三氮唑 | 202003-06-3 |
 |
(2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | (αS,βR)-β-(2,5-二氟苯基)-β-羟基-α-甲基-1H-1,2,4-三唑-1-丁腈 | 241479-74-3 |
 |
(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide | (2R, 3R)-3-(2, 5-二氟苯基)-3-羟基-2-甲基-4-[1H-(1, 2, 4)-三氮唑-1-基]硫代丁酰胺 | 368421-58-3 |
| The products under valid patents will not be offered to the countries covered by the patents. Any patent issues will be at buyer's responsibility. | |||
| End Use | Product Name | 品名 | Cas No. |
| Calcitriol 骨化三醇 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| Calcifediol 骨化二醇 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| Calcipotriol 卡泊三醇 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| Maxacalcitol马沙骨化醇 | API, Key intermediates | 原料药及关键中间体 | N/A |
| Eldecalcitol 艾地骨化醇 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| Travoprost 曲伏前列素 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| Tafluprost 他氟前列素 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| carboprost 卡前列素 |
API, Key intermediates | 原料药及关键中间体 | N/A |
| Dolutegravir 度鲁特韦 |
(R)-3-Aminobutan-1-ol | (R)-3-氨基-1-丁醇 | 61477-40-5 |
| Sacubitril 沙库必曲 |
(R)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbaMate | (R)-叔丁基 (1-([1,1'-联苯]-4-基)-3-羟基丙烷-2-基)氨基甲酸酯 | 1426129-50-1 |
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid | (2R,4S)-5-(联苯-4-基)-4-[(叔丁氧羰基)氨基]-2-甲基戊酸 | 1012341-50-2 | |
| Tranexamic acid 氨甲环酸 |
4-(Aminomethyl)benzoic acid | 4-(氨甲基)苯甲酸 | 56-91-7 |
| trans-4-aminomethylcyclohexane-1-carboxylate | 反式-4-(氨甲基)环己烷甲酸 | 1197-18-8 | |
| N/A 其他 |
2-Acetylthiophene | 2-乙酰噻吩 | 88-15-3 |
| The products under valid patents will not be offered to the countries covered by the patents. Any patent issues will be at buyer's responsibility. | |||
